tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OTLK Stock Latest News

Outlook Therapeutics 9.3M share Spot Secondary priced at $1.40
The FlyOutlook Therapeutics 9.3M share Spot Secondary priced at $1.40
6h ago
OTLK
Outlook Therapeutics Reports Improved Financials Amid Challenges
PremiumCompany Announcements
Outlook Therapeutics Reports Improved Financials Amid Challenges
14h ago
OTLK
Outlook Therapeutics announces common stock, warrants offering
PremiumThe Fly
Outlook Therapeutics announces common stock, warrants offering
22h ago
OTLK
Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
PremiumThe Fly
Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
3d ago
OTLK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7d ago
INM
XLO
Outlook Therapeutics reports Q2 EPS (40c), consensus (55c)
PremiumThe FlyOutlook Therapeutics reports Q2 EPS (40c), consensus (55c)
8d ago
OTLK
Outlook Therapeutics Approves Retention Incentive for CFO
Premium
Company Announcements
Outlook Therapeutics Approves Retention Incentive for CFO
1M ago
8K
OTLK
Outlook Therapeutics announces acceptance of BLA by U.S. FDA for ONS-5010
Premium
The Fly
Outlook Therapeutics announces acceptance of BLA by U.S. FDA for ONS-5010
2M ago
OTLK
Outlook Therapeutics files to sell 21.72M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics files to sell 21.72M shares of common stock for holders
2M ago
OTLK
Outlook Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Outlook Therapeutics management to meet virtually with BTIG
2M ago
OTLK
Outlook Therapeutics Issues Convertible Note to Avondale
PremiumCompany Announcements
Outlook Therapeutics Issues Convertible Note to Avondale
2M ago
8K
OTLK
Outlook Therapeutics files to sell 7.07M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics files to sell 7.07M shares of common stock for holders
3M ago
OTLK
Outlook Therapeutics re-submits BLA to U.S. FDA for ONS-5010
PremiumThe FlyOutlook Therapeutics re-submits BLA to U.S. FDA for ONS-5010
3M ago
OTLK
Outlook Therapeutics price target lowered to $10 from $12 at Guggenheim
Premium
The Fly
Outlook Therapeutics price target lowered to $10 from $12 at Guggenheim
3M ago
OTLK
Positive Outlook on Outlook Therapeutics: Buy Rating Supported by Strategic Launches and Market Opportunities for Lytenava
Premium
Ratings
Positive Outlook on Outlook Therapeutics: Buy Rating Supported by Strategic Launches and Market Opportunities for Lytenava
3M ago
OTLK
Outlook Therapeutics price target lowered to $3 from $30 at H.C. Wainwright
PremiumThe Fly
Outlook Therapeutics price target lowered to $3 from $30 at H.C. Wainwright
3M ago
OTLK
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OTLK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
OTLK
Outlook Therapeutics Reports Strong Earnings and Strategic Progress
PremiumCompany Announcements
Outlook Therapeutics Reports Strong Earnings and Strategic Progress
3M ago
OTLK
Outlook Therapeutics reports Q1 adjusted EPS (89c) vs. (78c) last year
PremiumThe Fly
Outlook Therapeutics reports Q1 adjusted EPS (89c) vs. (78c) last year
3M ago
OTLK
Outlook Therapeutics announces upcoming anticipated milestones
PremiumThe FlyOutlook Therapeutics announces upcoming anticipated milestones
3M ago
OTLK
Outlook Therapeutics Secures Funding and Board Restructures
Premium
Company Announcements
Outlook Therapeutics Secures Funding and Board Restructures
4M ago
8K
OTLK
Outlook Therapeutics appoints Sukhtian as Chairman of the board of directors
Premium
The Fly
Outlook Therapeutics appoints Sukhtian as Chairman of the board of directors
4M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >